Abstract
Background
Antimicrobial agents are one of the most important weapons in the resistance of infection caused by bacterial strains. In the past few years, increase the resistance of microorganisms toward antimicrobial agents become a serious health problem so there is a need of safe, potent and novel antimicrobial agents [1] . Pyrimidine aromatic heterocyclic moiety containing nitrogen atom at 1st and 3rd positions and play an important role to forms the central core for different necessity of biological active compounds [2] . Pyrimidine is the structural unit of DNA and RNA which play an imperative role in various existence progressions. Pyrimidines are present among the three isomeric diazines. Most abundant pyrimidine is uracil, cytosine and thymine [3] . These derivatives are also known as m-diazine or 1,3-diazone can be regarded as cyclic amine and shows the various biological activities i.e. antiviral [4, 5] ; anticancer [6] ; antimicrobial [7] ; antiinflammatory [8] ; analgesic [9] ; antioxidant [10] ; antimalarial [11] .
Pyrimidine is used as parent substance for the synthesis of a wide variety of heterocyclic compounds and raw material for the synthesis of new molecule [12] . Pyrimidine ring complexes with different heterocyclic moiety found to be an essential part of natural products agrochemicals and veterinary products. A large measure of antimicrobial drugs such as ciprofloxacin, chloramphenicol, griseofulvin and nystatin are available for bacterial and fungal infections [13] .
Recently, it was reported that p-methoxyphenyl group present on pyrimidine nucleus improved the antimicrobial activity of the pyrimidine derivative (I) [13] , p-Chloro phenyl group present on pyrimidine nucleus [14] improved the anticancer activity of the pyrimidine derivatives (II), p-Methoxyphenyl group present on pyrimidine derivatives (III) improved the antioxidant [15] , p-Methoxyphenyl group present on pyrimidine ring (IV) improved the antitubercular activity of the pyrimidine derivatives [16] , p-Hydroxy group present on pyrimidine nucleus (V) improved the antimicrobial of the pyrimidine compound [10] . The electron releasing (-OH and -OCH 3 ) and electron withdrawing (-Cl) groups are present on different position of pyrimidine nucleus (I, II, III, IV and V) enhanced the biological activity of the pyrimidine derivatives, from this facts we developed a design of reported biological active agents and proposed antimicrobial agent which is presented in Fig. 1 . In light of abovementioned facts, we hereby report to design, synthesis and antimicrobial screening of 4-(substituted phenyl)-6-(4-nitrophenyl) pyrimidin-2-ol/thiol/amine derivatives (Scheme 1a, b).
Results and discussion

Chemistry
Synthesis of pyrimidine derivatives (1-13) followed the general procedure discussed in synthetic Scheme 1a, b. The reaction of substituted chalcone in the presence of guanidine hydrochloride/urea/thiourea in methanolic solvent resulted in the formation of the final compounds. The physicochemical properties of newly synthesized compounds are presented in Table 1 . The molecular structures of the synthesized compounds (1-13) were confirmed by FT-IR (KBr pellets, cm . The impression of IR stretching at 2602-2627 and 623-709 cm −1 in the spectral data of synthesized compounds specified the existence of S-H and C-S group respectively. The appearance of IR stretching at 3379-3349 cm −1 spectral data of synthesized compounds specified the existence of -NH 2 group. The impression of IR stretching vibration at 3100-3000 and 1580-1600 cm −1 in the spectral data of synthesized compounds specified the existence of C-H and C=C group respectively.
The appearance of IR stretching 1670-1709 cm −1 in the spectral data of all synthesized compounds specified the existence of C=N group. The multiplet signals between 6.33 and 8.34 δ ppm in 1 H-NMR spectra is indicative of aromatic proton of synthesized derivatives. The compounds 8 and 9 showed singlet at 3.01-3.34 δ ppm due to the existence of OCH 3 of Ar-OCH 3 . All compounds showed singlet at 7.51-8.43 and 6.85-841 δ ppm due to the existence of N=CH and -CH groups in pyrimidine ring respectively. Compound 13 showed singlet at 2.19 δ ppm due to existence of -N(CH 3 ) 2 at the para position. Compounds, 1, 3, 5, 8, 11 and 12 showed singlet at 4.0-4.3 δ ppm due to existence of -NH 2 at the para position and 2, 4, 6 and 10 showed singlet at 3.01-3.34 δ ppm due to existence of -SH group at the para position of the pyrimidine ring. The elemental screened studies of the 4-(substituted phenyl)-6-(4-nitrophenyl) pyrimidin-2-ol/thiol/amine were found within ± 0.39% of the theoretical results.
In vitro antimicrobial activity
All the newly synthesized pyrimidine derivatives were examined for their in vitro antimicrobial activity against Gram positive S. aureus (MTCC 3160), B. subtilis (MTCC 441), Gram negative species: E. coli (MTCC 443), P. aeruginosa (MTCC 3542), S. enteric (MTCC 1165) and fungus species: A. niger (MTCC 281) and C. albicans (MTCC 227) strain using tube dilution method [17] . Dilutions of test and standard compounds were prepared in double strength nutrient broth for bacterial strains and sabouraud dextrose broth for fungal strains [18] . The minimum inhibitory concentration (MIC i.e. lowest concentration required of test substance to complete growth inhibition) values of standard drugs and synthesized compounds are presented in Table 2 . From the results of antimicrobial evaluation it was observed that the entire synthesized compounds showed appreciable antimicrobial activity and different compounds were found to be active against different microorganisms. In case of Gram positive bacteria, compounds 12 (MIC sa = 0.87 µM/ ml) showed significant activity against S. aureus and 5 (MIC bs = 0.96 µM/ml) exhibited most potent antibacterial activity against B. subtilis. In case of Gram negative bacteria, compounds 10 (MIC se = 1.55 µM/ml) showed significant activity against Salmonella enteric, 2 (MIC ec = 0.91 µM/ml) displayed more potent antibacterial activity against E. coli and 10 (MIC pa = 0.77 µM/ ml) exhibited most potent antibacterial activity against P. aeruginosa. Compound 12 (MIC ca = 1.73 µM/ml) showed significant activity against C. albicans and 11 (MIC an = 1.68 µM/ml) was found to be most potent antifungal agent against A. niger. All synthesized compounds having more antimicrobial potential than the standard cefadroxil (antibacterial) and fluconazole (antifungal) drugs and these compounds may be used as lead for the further discovery of new antimicrobial agents.
Determination of MBC/MFC
After recorded the MIC results of the synthesized compounds in concentration of (50, 25, 12.5, 6.25, 3.125, 1.56) µM/ml against microbial species i.e. Gram positive bacteria (S. aureus and B. subtilis), Gram negative bacteria (E. coli, P. aeruginosa and S. enterica) and fungal strain (C. albicans and A. niger) then their minimum bactericidal concentration (MBC) and fungicidal concentration (MFC) were determined by petri dish method using nutrient agar media (antibacterial) and sabouraud dextrose agar media (antifungal) by subculturing 100 μl of culture from each test tube that remained clear in the [19] .
SAR (structure activity relationship) studies
From the antimicrobial testing results of synthesized 4-(substituted phenyl)-6-(4-nitrophenyl)pyrimidin-2-ol/ thiol/amine derivatives, the subsequent structure activity relationship can be derived in Fig. 2 . 
General procedure for synthesized pyrimidine analogues
Step i: synthesis of substituted chalcone (intermediate-I) The reaction mixture of 1-(4-nitrophenyl)ethanone (0.01 mol) and corresponding aldehyde (0.01 mol) were stirred for 2-3 h in methanol (5-10 ml) followed by drop wise addition of sodium hydroxide solution (10 ml 40%) with constant stirring at room temperature. Then reaction mixture was taken overnight at room temperature and then was poured into ice cold water and acidified with hydrochloric acid and the precipitated substituted chalcone was filtered, dried and recrystallized from methanol [20] .
Step ): 2931 (C-H str.), 1596 (C=C str.), 700 (C-C str.), 1688 (C=N str. or N=CH str., pyrimidine ring), 1344 (C-N str., pyrimidine), 754 (C-Cl str.), 1521 (NO 2 asym str.), 854 (C-N str., Ar-NO 2 ), 3379 (NH 2 asym str.); ): 2947 (C-H str.), 692 (C-C str.), 1709 (C=N str. pyrimidine ring), 1344 (C-N str., pyrimidine), 784 (C-N str., Ar-NO 2 ), 1041 (C-O-C str., -OCH 3 ), 2839 (C-H str., R-CH 3 ); 13 ): 2937 (C-H str.), 1604 (C=C str.), 694 (C-C str.), 1661 (C=N str.), 1349 (C-N str., pyrimidine), 1502 (NO 2 asym str., phenyl ring), 752 (C-N str., Ar-NO 2 ),
ii: synthesis of 4-(substituted phenyl)-6-(4-nitrophenyl)pyrimidin-2-ol/thiol/amine derivatives
4-(4-Chlorophenyl)-6-(4-nitrophenyl)pyrimidin-2-ol
